Key result
The highly conserved CNOT1 Interacting Motif (CIM) of Tristetraprolin (TTP) remains unphosphorylated by MK2 and promotes mRNA deadenylation and decay independently of the p38 MAPK-MK2 pathway.
This basic science study demonstrates that TTP-mediated mRNA decay is cooperatively regulated by multiple kinase pathways, with the CIM acting independently of the p38 MAPK-MK2 pathway.
Should not yet inform clinical practice; leaves open CIM as MK2-independent regulator of mRNA decay.
Summary Regulation of the mRNA decay activator Tristetraprolin (TTP) by the p38 mitogen-activated protein kinase (MAPK) pathway during the mammalian inflammatory response represents a paradigm for the regulation of mRNA turnover by signaling. Phosphorylation of TTP by p38 MAPK-activated kinase 2 (MK2) inhibits the association of TTP with the CCR4-NOT deadenylase complex and represses TTP-mediated mRNA decay. Here we present evidence that TTP remains active in the presence of activated MK2 due to its highly conserved CNOT1 Interacting Motif (CIM), which remains unphosphorylated and capable of promoting deadenylation and decay. The CIM recruits the CCR4-NOT complex cooperatively with previously identified conserved tryptophan residues of TTP and deletion of the CIM strongly represses residual association with the deadenylase complex and activity of TTP in conditions of active MK2. A conserved serine in the CIM is not a target of MK2 but is instead phosphorylated by other kinases including the PKCα pathway and regulates TTP activity independently of MK2. These results suggest that kinase pathways regulate TTP activity in a cooperative manner and that the p38 MAPK-MK2 pathway relies on the activation of additional kinase pathway(s) to fully control TTP function.
No takes yet. Share an insight, caveat, or question.
Carreño et al. (2022) studied this question. TTP CIM mutations and MK2 pathway manipulation vs. Wild-type TTP and inactive MK2 was evaluated on mRNA decay rate and deadenylation. The highly conserved CNOT1 Interacting Motif (CIM) of Tristetraprolin (TTP) remains unphosphorylated by MK2 and promotes mRNA deadenylation and decay independently of the p38 MAPK-MK2 pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: